Ardent Health, Inc.

Ardent Health, Inc. announced the appointment of Dave Caspers as its new President and Chief Executive Officer, effective June 2, 2026. Mr. Caspers, previously the Chief Operating Officer, also joins the Board of Directors. He succeeds Martin J. Bonick, who has stepped down from both roles. The company reaffirmed its full-year 2026 Adjusted EBITDA guidance of $485 million to $535 million, despite observing volume softness in Q2.

Ardent Health, Inc. reported a 7.0% increase in total revenue, reaching $1.60 billion for the first quarter of 2026. Despite the revenue growth, net income attributable to Ardent Health, Inc. decreased by 3.7% to $39.85 million, resulting in diluted earnings per share of $0.28. The company experienced higher operating expenses, particularly in professional fees and other operating costs, and a significant increase in cash used in operating activities.

Ardent Health, Inc. announced its first quarter 2026 financial results, reporting a 7.0% year-over-year increase in total revenue to $1.60 billion and a 26.3% rise in Adjusted EBITDA to $124 million. Net income attributable to Ardent Health was $40 million, or $0.28 per diluted share. Despite a 1.1% decrease in total admissions due to severe weather and a lighter respiratory season, adjusted admissions grew by 2.0%. The company reaffirmed its full-year 2026 financial guidance, citing strong execution and effective cost management, including $55 million in anticipated savings from its IMPACT program.